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ABSTRACT
Introduction: Primary aldosteronism affects 5% to 13% of
patients with hypertension. Idiopathic bilateral hyperpla-
sia (IHA) and unilateral aldosterone-producing adenoma
(APA) are the most common types of primary aldosteron-
ism. Bilateral APA is a very rare entity with only a few
reports in the literature. We present the case of a patient
with metachronous bilateral APA treated with metachro-
nous bilateral total and near total adrenalectomy.
Case Report: A 66-year-old female was evaluated for
hypokalemia and hypertension refractory to medical ther-
apy 2 years after laparoscopic adrenalectomy for right
APA. Follow-up abdominal CT scan revealed a new
1.1-cm left adrenal mass. The patient underwent a lapa-
roscopic near total adrenalectomy for her new left adrenal
mass. Pathology examination revealed a new APA. The
operation and the patient’s postoperative course were
uneventful. Potassium levels were normalized and her
hypertension became well controlled.
Conclusion: APA can present metachronously months to
years after adrenalectomy for APA in the contralateral
adrenal gland. Laparoscopic adrenalectomy remains the
approach of choice for this pathology.
Key Words: Conn’s syndrome, Metachronous adenoma,
Hypertension, Aldosterone-producing adenoma, Laparo-
scopic adrenalectomy.
INTRODUCTION
It is estimated that approximately 28.7% of the total US
population are hypertensive.1 The most common form of
secondary hypertension is primary hyperaldosteronism,
first described by Conn in 1955.2 Primary aldosteronism
has been shown to affect 5% to 13% of nonselected pa-
tients with hypertension.3,4 It is characterized by excess
plasma aldosterone leading to suppression of renin levels,
hypertension, and hypokalemia. Many patients will not be
hypokalemic,5–8 and the plasma aldosterone concentra-
tion (PAC) to plasma renin activity (PRA) ratio is widely
accepted as the screening test of choice for primary aldo-
steronism.4,9,10 Idiopathic bilateral hyperplasia (IHA) and
aldosterone-producing adenoma (APA) are the most com-
mon subtypes of primary aldosteronism, comprising ap-
proximately 65% and 30% of cases, respectively.3 Less
common subtypes of primary aldosteronism include uni-
lateral hyperplasia in 3% of patients, aldosterone-produc-
ing adrenocortical carcinoma in 1% of patients and famil-
ial hyperaldosteronism in 1% of patients.4 Patients with
APA tend to have more severe hypertension, more fre-
quent hypokalemia, higher plasma (25ng/dL) and uri-
nary (30g/24h) levels of aldosterone, and are younger
(50 years old) than those with IHA.3,11,12 Initial testing
should include CT scan imaging of the adrenal glands.
Selective adrenal venous sampling is the most accurate
method for distinguishing the difference between unilat-
eral and bilateral adrenal aldosterone hypersecretion.4,13
Bilateral IHA may be treated pharmacologically with min-
eralcorticoid receptor antagonists; however, the optimal
treatment for APA or unilateral hyperplasia involves sur-
gical intervention.4 Laparoscopic adrenalectomy is re-
garded as the gold-standard therapy for benign lesions of
the adrenal gland.14–18 Bilateral APA is an extremely rare
entity with only a few reports in the literature.19–21 We
describe the case of a patient with metachronous bilateral
APAs with left APA identified 2 years after total adrenal-
ectomy for right APA.
CASE REPORT
A 66-year-old woman was evaluated for recurrence of
hypokalemia and poorly controlled hypertension. Two
years before this presentation, she underwent a laparo-
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CASE REPORTscopic right adrenalectomy for a 1-cm hyperfunction-
ing right adrenal mass found on abdominal CT scan
(Figure 1A) with a normal-appearing left adrenal gland
(Figure 1B). The site of her hyperaldosteronism was
confirmed with selective adrenal venous sampling to the
right adrenal that corresponded to the right aldosterone-
producing adenoma. Surgical pathology at the time re-
vealed an adrenal cortical adenoma measuring 1cm x 1cm
x 0.8cm consistent with aldosteronoma (Figure 2). The
patient was discharged on the second postoperative day
after an uneventful recovery. Her hypokalemia resolved,
her blood pressure normalized on anti-hypertensive med-
ications, and her aldosterone level returned to normal.
Two years later, the patient developed signs of recurrent
hyperaldosteronism with hypertension refractory to anti-
hypertensive medication, hypokalemia as well as elevated
aldosterone level and suppressed serum renin. Follow-up
CT scan revealed radiological features of a new 1.1-cm left
adrenal nodule (Figure 3) and absent adrenal gland on a
right side consistent with a new contralateral hyperfunc-
tioning left adrenal adenoma. Her blood pressure was
195/102mm Hg, plasma renin activity (PRA) was 0.24ng/
mL/hr, plasma aldosterone concentration was 20.9ng/dL,
and the PAC to PRA ratio was 87.08ng/dL per ng/mL/hour,
consistent with second primary hyperaldosteronism. At
this time, the patient underwent a laparoscopic left near
total adrenalectomy for the new adrenal mass that was
confirmed to be an adrenal cortical adenoma measuring
1cm x 0.7cm x 0.6cm (Figure 4). We defined a term near
total adrenalectomy as a near total excision of the adrenal
gland containing an adenoma and most of the adjacent
normal adrenal gland and leavening only a rim of normal
adrenal tissue in the superior pole of the gland away from
the adenoma. Postoperative serum examination revealed
PAC of 3ng/dL and PRA of 0.30ng/mL/hr. Figure 5 dem-
onstrates changes in the patient’s PAC over the course of
2 years. After initial normal levels of serum cortisol for the
first 10 days postoperatively, the patient was advised by
her endocrinologist to take 20mg of oral hydrocortisone
twice daily and 0.25mg of fludrocortisone daily, which
was later reduced to hydrocortisone 10mg in the morning
Figure 1. (A) CT of the abdomen with contrast demonstrates a
1-cm nodule in the right adrenal gland consistent with benign
adenoma (arrow). (B) The same CT of the abdomen showing a
normal left adrenal gland (arrow).
Figure 2. Histopathology (H&E, 100X) of right adrenal gland
nodule after right adrenalectomy is consistent with APA.
Figure 3. CT of the abdomen with contrast (2 years after right
adrenalectomy) demonstrates a new 1.1-cm nodule with non-
specific characteristics in the left adrenal gland consistent with
benign adenoma (arrow).
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dose of fludrocortisone. She subsequently continued to
require hormone replacement therapy, and her ACTH
levels were high and consistent with the primary adrenal
insufficiency. This was most likely either the result of the
insufficient mass of the remaining adrenal tissue that was
left, or a secondary event leading to adrenal insufficiency.
On a 2-year follow-up, the patient remains clinically well,
her blood pressure is well controlled, potassium levels
were normal, and potassium supplementation was dis-
continued. The patient continues to require hormone re-
placement therapy.
DISCUSSION
Adrenal masses occur bilaterally in 15% of adrenal inci-
dentalomas. The differential diagnosis includes metastatic
disease, congenital adrenal hyperplasia, lymphoma, infec-
tion (tuberculosis, fungal), hemorrhage, adrenocortico-
tropic hormone (ACTH)-dependent Cushing’s syndrome,
pheochromocytoma, and infiltrative diseases, such as am-
yloidosis.22 Bilateral synchronous APA is a rare entity with
few reports in the literature.19–21 Recognizing that most
bilateral adrenal masses have been reported to be meta-
static tumors, a retrospective study of 18 cases of bilateral
adrenal masses by Zhou et al21 reported common causes
to be pheochromocytoma, primary lymphoma, and non-
functioning cortical adenoma, with only one case due to
primary aldosteronism. We describe a rare case of meta-
chronous adrenal APA 2 years following adrenalectomy of
the contralateral APA. The review of the literature has
identified only one paper (Chinese literature) reporting
such cases.20 Several features support our observation of
this pathology not to be due to bilateral hyperplasia. First,
there was a normal-appearing left adrenal gland on the
initial CT scan and clearly demonstrated 1-cm nodule on a
right adrenal gland. Second, the selective venous sam-
pling localized the hyperfunctioning gland to the right.
Finally, the pathology revealed adenomas in both cases
and not hyperplasia.
Screening for primary hyperaldosteronism should be con-
sidered in a patient with hypertension and hypokalemia,
resistant hypertension, finding of an adrenal incidenta-
loma on CT or MRI and hypertension, or whenever con-
sidering secondary hypertension. Screening can be ac-
complished by a morning blood sample in a seated
ambulatory patient for PAC and PRA with a PAC to PRA
ratio 20ng/dL per ng/mL/hr and PAC15ng/dL with
subsequent investigation of primary aldosteronism.3,23 Se-
lective adrenal venous sampling is the most accurate
method for determining the site of aldosterone overpro-
duction4,13 or when CT scan is equivocal to avoid wrong-
site adrenalectomy.24 A gradient of aldosterone to cortisol
ratio of more than 4 between the left and right adrenal
vein is consistent with unilateral aldosterone excess and
indicates the presence of an APA, or, infrequently, unilat-
eral hyperplasia or aldosterone-producing carcinoma.13
Our patient presented with hypertension refractory to
medical treatment 2 years after her first adrenalectomy for
right APA. The increase in her PAC and decrease in PRA,
and more importantly the PAC to PRA ratio of 87.08ng/dL
per ng/mL/hour along with the new left-sided nodule
confirmed on CT scan was consistent with new metachro-
nous APA.
Laparoscopic adrenalectomy is regarded as the gold stan-
dard for benign lesions 6cm of the adrenal gland. It is
less invasive with minor operative blood loss, a lower
analgesic requirement, earlier oral intake, better cosmesis,
lower morbidity, and faster recovery.14–18 Simultaneous
adrenalectomy has also been shown to be safe and effec-
Figure 4. (A) Left adrenal gland with 1.1-cm nodule (arrow) that
was identified as an APA after left adrenalectomy 2 years after
right adrenalectomy for right APA. (B) Histopathology (H&E,
100X) of the specimen is consistent with APA.
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pheochromocytoma.18,25 One study describes a rare case
of recurring APA 9 years postadenomectomy, in which the
authors concluded in that case that enucleation may not
be adequate therapy for patients with APA, and a com-
pletion adrenalectomy of the affected adrenal gland cured
this patient of the recurrent disease.26 There are no data
comparing enucleation or near total adrenalectomy with a
total adrenalectomy as a treatment for hyperfuncioning
adenomas. Fortunately, this clinical dilemma is not perti-
nent to the overwhelming majority of clinical situations,
because bilateral aldosterone-producing adenomas are
exceptionally rare; therefore, at the present time such a
study is impossible to conduct. In addition, we postulate
that near-total adrenalectomy is a different procedure than
enucleation of the adenoma. In the presented case, we
excised the adenoma with at least a 1-cm margin of the
adjacent normal gland, leaving only a rim of normal ad-
renal tissue in the superior pole of the gland. This clinical
decision was based on the presumption that the remain-
ing normal adrenal tissue may offer some protection for
the patient if lost to follow-up or other adverse events. We
suggest that, weighing overall risks and benefits, to pre-
serve some adrenal function, a near-total adrenalectomy
of the contralateral gland may be considered in such
cases. Long-term follow-up of this patient and possibly
future similar case series may only be able to address this
clinical issue in a more methodological way.
In the majority of patients with surgically managed APA,
control of blood pressure improves, and serum potassium
levels normalize. Between 33% and 73% will become
normotensive without the aid of antihypertensive medi-
cations.13,27–29 Some cases have demonstrated persistent
hyperaldosteronism after adrenalectomy.30 In the pre-
sented case, the patient underwent bilateral metachro-
nous laparoscopic adrenalectomy, total on the right and
near total on the left. This patient experienced resolution
of hypokalemia and, on follow-up, her hypertension was
well-controlled.
CONCLUSION
Although very rare, APA can present metachronously
months to years after total adrenalectomy for APA in the
contralateral adrenal gland. More studies are needed to
determine the optimal surgical management in this rare
clinical scenario.
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